Physician profile
Amy M Ballard
NPI 1528153558
$38,414.20
in general payments reported to CMS, 2019-2025
18 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10K · 2022: $11K · 2023: $528 · 2024: $5,693 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,288 · Honoraria: $4,414 · Consulting Fee: $2,788 · Food and Beverage: $2,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,287.71 |
| Honoraria | $4,413.75 |
| Consulting Fee | $2,787.50 |
| Food and Beverage | $2,251.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $36,364.00 | 2021-2025 | Tymlos |
| Amgen INC. | $752.54 | 2021-2025 | Evenity, Prolia, Prolia |
| Bioventus LLC | $287.28 | 2021-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $262.92 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Sanara Medtech INC. | $132.12 | 2025 | Celleraterx |
| Smith+Nephew, INC. | $112.84 | 2022-2023 | Renasys Go V2 Home |
| Abiomed | $85.55 | 2024 | Impella |
| Csl Behring | $78.44 | 2021-2025 | Kcentra |
| Pfizer INC. | $70.19 | 2022-2024 | |
| Access Pro Medical, LLC | $63.00 | 2023-2025 | Matriderm, Matriderm |
| Si-Bone, INC. | $49.58 | 2022 | |
| Organogenesis INC. | $40.29 | 2023 | Puraply |
| Dilon Technologies, INC. | $32.54 | 2025 | Hemoblast Bellows |
| Ethicon US, LLC | $20.28 | 2023 | Stratafix |
| Lifenet Health | $20.11 | 2025 | Theragenesis Wound Matrix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alvogen INC | $14.91 | 2021 | |
| Convatec INC. | $14.89 | 2023 | |
| Reprise Biomedical, INC. | $12.72 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Ballard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.